Published in Hepatitis Weekly, September 11th, 2006
"Patients with recurrent hepatitis C after liver transplantation usually have a high viral load and are generally resistant to interferon (IFN)-alpha 2b plus ribavirin (RBV) therapy. However, it remains unclear whether pretreatment viral titer determines the effectiveness of combination therapy, especially in patients with a high viral load.
"The aim of this study was to identify the viral factors associated with a sustained virological response (SVR) to antiviral therapy in patients...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.